Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 227

Beam hits series B with $135m

GV participated as a new investor, as genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.

Mar 7, 2019

Wefox sniffs out $125m in series B

The Salesforce-backed online insurance platform is reportedly valued at nearly $1bn having raised funding from investors including CreditEase.

Mar 7, 2019

Delhivery carries off $395m in series F round

SoftBank Vision Fund invested $350m in Delhivery at a $1.6bn valuation as part of a $395m round, and it now owns a 23.4% stake in the logistics services provider.

Mar 6, 2019

Chime strikes a $200m chord with investors

Northwestern Mutual-backed digital bank Chime is now valued at $1.5bn following a series D round led by DST Global.

Mar 6, 2019

Dream11 to realise another $100m funding dream

The Tencent-backed fantasy sports platform will reportedly be valued at between $1.3bn and $1.5bn following the rumoured $100m investment from Steadview Capital.

Mar 6, 2019

Zomato gets $50m boost from Delivery Hero

Delivery Hero has confirmed a $50m investment in the food listings and ordering platform as part of a $105m second tranche of a round that now totals $315m.

Mar 5, 2019

Ayana gets $330m recharge

The renewable energy project developer raised the cash in a round led by Eversource Capital, which is 50% owned by power producer Lightsource BP.

Mar 5, 2019

Go-Jek accepts $100m from Astra

Astra International has committed $100m in series F capital to Go-Jek as part of an agreement to integrate the corporate’s fleet management system into Go-Jek’s vehicles.

Mar 4, 2019

Analysis: DoorDash gets $400m order

Last-mile consumer goods delivery service provider DoorDash raised $400m, from SoftBank´s Vision Fund at a valuation of $7.1bn

Mar 4, 2019

Maze finds its way to $191m

GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.

Mar 1, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here